Answer
Blincyto (blinatumomab) must not be mixed with other medicinal products except those mentioned in section 6.6 of its SmPC.
Sources for this answer
- BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusionAmgen Ltd · emc · SmPC §6.2 Incompatibilities · Version 26Document updated
Sources checked